| Style | Citing Format |
|---|---|
| MLA | Asilian A, et al.. "Comparison of Telogen Effluvium Incidence in Hospitalized and Outpatient Settings After Recovery From Covid-19." Iranian Journal of Medical Sciences, vol. 49, no. 2, 2024, pp. 134-136. |
| APA | Asilian A, Iraji F, Hosseini SM, Dehkordi PM (2024). Comparison of Telogen Effluvium Incidence in Hospitalized and Outpatient Settings After Recovery From Covid-19. Iranian Journal of Medical Sciences, 49(2), 134-136. |
| Chicago | Asilian A, Iraji F, Hosseini SM, Dehkordi PM. "Comparison of Telogen Effluvium Incidence in Hospitalized and Outpatient Settings After Recovery From Covid-19." Iranian Journal of Medical Sciences 49, no. 2 (2024): 134-136. |
| Harvard | Asilian A et al. (2024) 'Comparison of Telogen Effluvium Incidence in Hospitalized and Outpatient Settings After Recovery From Covid-19', Iranian Journal of Medical Sciences, 49(2), pp. 134-136. |
| Vancouver | Asilian A, Iraji F, Hosseini SM, Dehkordi PM. Comparison of Telogen Effluvium Incidence in Hospitalized and Outpatient Settings After Recovery From Covid-19. Iranian Journal of Medical Sciences. 2024;49(2):134-136. |
| BibTex | @article{ author = {Asilian A and Iraji F and Hosseini SM and Dehkordi PM}, title = {Comparison of Telogen Effluvium Incidence in Hospitalized and Outpatient Settings After Recovery From Covid-19}, journal = {Iranian Journal of Medical Sciences}, volume = {49}, number = {2}, pages = {134-136}, year = {2024} } |
| RIS | TY - JOUR AU - Asilian A AU - Iraji F AU - Hosseini SM AU - Dehkordi PM TI - Comparison of Telogen Effluvium Incidence in Hospitalized and Outpatient Settings After Recovery From Covid-19 JO - Iranian Journal of Medical Sciences VL - 49 IS - 2 SP - 134 EP - 136 PY - 2024 ER - |